What is BMY's market cap?

$131.21B, based on the Nov 4 close of $64.19.

What is BMY's P/E ratio?

14.1× trailing-twelve-month earnings of $9.28B.

Does Bristol-Myers Squibb pay a dividend?

Yes. The latest regular dividend was $0.63 per share (ex-date Oct 2), an annualised yield of 3.93%.

How much of BMY is sold short?

49.9M shares, 2.5% of float, as of Oct 15, 2026.

What sector is BMY in?

Healthcare, in the Pharmaceuticals industry.

NYSE · BMYHealthcarePharmaceuticals

Bristol-Myers Squibb Co. (BMY)

$64.19+4.02%

Close Nov 4, 2026 · split-adjusted

Nov 4, 2026$63.20▲ 37.32% in range

Nov 3, 2025Low $45.59 · High $68.09Nov 4, 2026

What changed · written from our data

As of Nov 4, 2026

Bristol-Myers Squibb closed at $64.19 on Nov 4, up 4.02%, 5.7% below its 52-week closing high. Volume of 14.1M shares was 1.16× its 20-day average (close to normal).

Split-adjusted performance: +7.7% over one month, +13.4% over six months, +39.5% over one year.

In the quarter ended Jun 30, 2026, revenue was $12.97B, up 5.7% from a year earlier, with a net margin of 25.6%.

Short interest was 49.9M shares at the Oct 15 settlement, up 8.9% from the prior report (2.5% of float, 3.6 days to cover).

Market cap$131.21B2.04B shares

Revenue · quarter$12.97B+5.7% YoY

Diluted EPS$1.62+153.1% YoY

P/E · TTM14.1×P/S 2.7×

Net margin25.6%Gross 71.3%

Dividend yield3.93%$0.63 last paid

52-week range45.59 – 68.09−5.7% from high

Volume14.1M1.16× 20-day avg

Volatility · 60d28.5%Annualised

Short % of float2.5%3.7 days to cover

Net cash-$32.05BCash $11.07B

Next earnings—Not scheduled

Split-adjusted performance

1W +6.0%1M +7.7%3M +0.1%6M +13.4%YTD +19.0%1Y +39.5%3Y +25.2%5Y +13.6%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Pharmaceuticals

Percentile among 420 companies (100 = best)

6-month momentum78

Revenue growth48

Net margin88

Value (low P/E)59

Size98

Industry medians: 6-month return −25.5%, revenue growth +6.2%, net margin −33.8%, P/E 16.1×.

Short interest

Details →

Shares short49.9M+8.9% vs prior

Days to cover3.7Settled Oct 15

% of float2.5%

Short vol. 10d45.9%of daily volume

Closest peers by size in Pharmaceuticals

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
BMYBristol-Myers Squibb	$64.19	+4.02%	+13.4%	+5.7%	25.6%	14.1	$131.21B
VRTXVertex Pharmaceuticals	$549.04	+3.44%	+28.4%	+11.8%	19.0%	35.0	$139.16B	Compare
PFEPfizer	$30.79	+2.63%	+16.1%	+2.6%	−1.6%	40.5	$175.49B	Compare
REGNRegeneron Pharmaceuticals	$930.67	−4.39%	+29.1%	+36.3%	38.1%	20.0	$96.28B	Compare
ABTAbbott Laboratories	$115.51	+5.58%	+33.8%	+13.0%	7.4%	36.8	$199.88B	Compare
TEVATeva Pharmaceutical Industries Limited	$41.85	−0.14%	+15.2%	−0.8%	−13.9%	69.0	$48.81B	Compare
MRKMerck & Co.	$150.36	+3.93%	+32.4%	+5.1%	−8.0%	116.9	$370.96B	Compare
ZTSZOETIS	$89.20	+7.48%	−19.8%	−0.2%	28.0%	14.1	$36.86B	Compare
ABBVABBVIE	$294.83	+3.09%	+43.8%	+10.3%	24.2%	50.4	$521.00B	Compare

News about Bristol-Myers Squibb

All news →

Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should KnowZacks Investment Research · 17h agoNeutral BMY Up 3% Post Q3 Earnings: Should You Buy, Sell or Hold the Stock?Zacks Investment Research · 2d agoNeutral BMY Q3 Earnings Call Highlights Raised Outlook and Pipeline ProgressZacks Investment Research · 5d agoNeutral BMY Q3 Earnings Tops Estimates, Higher Charges Weigh on OutlookZacks Investment Research · 6d agoNeutral Should You Buy, Hold, or Sell BMY Stock Ahead of Q3 Earnings?Zacks Investment Research · Oct 26, 2026Neutral

Quick answers

What does Bristol-Myers Squibb do?: Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development.
What is BMY's market cap?: $131.21B, based on the Nov 4 close of $64.19.
What is BMY's P/E ratio?: 14.1× trailing-twelve-month earnings of $9.28B.
Does Bristol-Myers Squibb pay a dividend?: Yes. The latest regular dividend was $0.63 per share (ex-date Oct 2), an annualised yield of 3.93%.
How much of BMY is sold short?: 49.9M shares, 2.5% of float, as of Oct 15, 2026.
What sector is BMY in?: Healthcare, in the Pharmaceuticals industry.

About Bristol-Myers Squibb

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

HQ: Princeton, NJ32,500 employeesListed Jun 23, 1952bms.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology